CSIMarket


Haemonetics Corporation  (HAE)
Other Ticker:  
 

Haemonetics Corporation

HAE's Fundamental analysis








Looking into Haemonetics growth rates, revenue grew by 17.53 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 1662

Medical Equipment & Supplies industry recorded growth of revenues by 5.31 %

Haemonetics's net income grew by 41.8 % in III. Quarter 2022 year on year, above company average,

More on HAE's Growth


Haemonetics
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Haemonetics PEG ratio is at 0.13 Haemonetics realized cash outflow of $ -0.25per share in trailing twelve-month period.
Company
41.88
PE TTM   
Industry
45.91
PE TTM    
Company's Price to Sales ratio is at 3.51.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.56.


More on HAE's Valuation
 
 Total Debt (Millions $) 767
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 7.04
 Tangible Book Value (Per Share $) 0.50

Haemonetics
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Haemonetics PEG ratio is at 0.13 Haemonetics realized cash outflow of $ -0.25per share in trailing twelve-month period.
Company
41.88
PE TTM   
Industry
45.91
PE TTM    
Company's Price to Sales ratio is at 3.51.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.56.

Haemonetics Price to Book Ratio is at 5.11 lower than Indusry Avg. of 485.92. and higher than S&P 500 Avg. of -0.01

More on HAE's Valuation

  Market Capitalization (Millions $) 3,965
  Shares Outstanding (Millions) 51
  Employees -
  Revenues (TTM) (Millions $) 1,129
  Net Income (TTM) (Millions $) 96
  Cash Flow (TTM) (Millions $) -13
  Capital Exp. (TTM) (Millions $) -133
  Total Debt (Millions $) 767
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 7.04
  Tangible Book Value (Per Share $) 0.50

  Market Capitalization (Millions $) 3,965
  Shares Outstanding (Millions) 51
  Employees -
  Revenues (TTM) (Millions $) 1,129
  Net Income (TTM) (Millions $) 96
  Cash Flow (TTM) (Millions $) -13
  Capital Exp. (TTM) (Millions $) -133


    HAE's Profitability Comparisons
Haemonetics faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2022 to 14.18 % from 15.71 % in II. Quarter.

Haemonetics net profit margin of 10.79 % is currently ranking no. 27 in Medical Equipment & Supplies industry, ranking no. 105 in Healthcare sector and number 1173 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.11
  Total Debt to Equity (MRQ) 0.99
  Tangible Leverage Ratio (MRQ) 38.6
  Asset Turnover Ratio (TTM) 0.61
  Inventory Turnover Ratio (TTM) 1.89



Haemonetics faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2022 to 14.18 % from 15.71 % in II. Quarter.

Haemonetics net profit margin of 10.79 % is currently ranking no. 27 in Medical Equipment & Supplies industry, ranking no. 105 in Healthcare sector and number 1173 in S&P 500.

More on HAE's Key Ratios



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TPST's Profile

Stock Price

TPST's Financials

Business Description

Fundamentals

Charts & Quotes

TPST's News

Suppliers

TPST's Competitors

Customers & Markets

Economic Indicators

TPST's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071